Basilea Pharmaceutica AG | Income Statement
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
40,950.70
42,498.80
51,654.00
65,984.00
101,521.00
132,555
Cost of Goods Sold (COGS) incl. D&A
-
-
-
5,347.00
9,025.00
20,299
Gross Income
-
-
-
60,637.00
92,496.00
112,256
SG&A Expense
71,962.10
81,873.10
111,783.00
104,526.00
106,632.00
136,351
EBIT
33,711.40
41,965.00
62,656.00
43,889.00
14,136.00
24,095
Non Operating Income/Expense
345.50
81.60
1,130.00
1,631.00
4,819.00
3,129
Interest Expense
-
-
154.00
8,730.00
9,731.00
10,219
Pretax Income
32,992.60
41,519.20
61,520.00
50,954.00
19,026.00
31,160
Income Tax
27.30
26.30
83.00
333.00
334.00
192
Consolidated Net Income
33,019.90
41,545.50
61,603.00
51,287.00
19,360.00
31,352
Net Income
33,019.90
41,545.50
61,603.00
51,287.00
19,360.00
31,352
Net Income After Extraordinaries
33,019.90
41,545.50
61,603.00
51,287.00
19,360.00
31,352
Net Income Available to Common
33,019.90
41,545.50
61,603.00
51,287.00
19,360.00
31,352
EPS (Basic)
3.40
4.17
6.09
5.07
1.79
2.89
Basic Shares Outstanding
9,712.60
9,953.90
10,112.20
10,121.10
10,845.90
10,837.90
EPS (Diluted)
3.40
4.17
6.09
5.07
1.79
2.89
Diluted Shares Outstanding
9,712.60
9,953.90
10,112.20
10,121.10
10,845.90
10,837.90
EBITDA
31,011.40
39,374.20
60,129.00
41,570.00
12,145.00
22,243
Non-Operating Interest Income
373.30
364.20
160.00
34.00
22.00
25
About Basilea Pharmaceutica
View Profile
